NFKB1 and melanoma: In general, such as in other human cancers [182], in the initial stages of melanoma, NF-κB might be considered a tumor-suppressor rather than a tumor-enhancer, while during melanoma progression, there is a reversal of its role, and NF-κB promotes the expression of a wide range of genes involved in tumor malignant progression.